Anavex Life Sciences Corp (AVXL)

[TomP1]

Most recent info out is in the LPC prospectus. This only mentions 2017 for Rett p2, no timeframe for AD p2 start, no mention of MS,...

Credit to Amatuer17

Amatuer17 Friday, 09/08/17 06:22:01 AM
Re: None
Post # of 119955
Yesterday's prospectus is very clear - it gives clues

1. Rett trial - got 0.6 million from Rett foundation - will start in calendar year 2017
"..The Phase 2 trial is scheduled to begin in calendar 2017 and will be a randomized, double blind, placebo-controlled study of ANAVEX TM 2-73 in patients with Rett syndrome lasting up to 12 week"

2. ALZ trial - is planning phase - it does not say anything about starting in 2017 like Rett - this is deliberate omission on starting date as they are not sure

3. Parkinson Trial - it talks about preclinical funding by MJFF but no mention of funding for actual trial and date

4. MS - there is absolutely no mention of MS in preclinical or pipeline. Also there is no mention of Biogen MTD in entire document

5. Partnership - "We intend to identify and initiate discussions with potential commercial partners within the next 12 months..."

These prospectus are strong legal documents as they are related to raising money. Co avoids to put anything in it that even remotely seems false or incorrect.

As such I tend to take them seriously and believe what is said and not guess what is not said.

Based in what is not said - starting ALZ and PD trial in 2017 - will not believe unless Dr M reiterates again in a conference or issues a new PR
MJFF funding not available
Biogen MTD not a positive news else they would have at least mentioned one line about MTD